RenovoRx, Inc. IPO

Completed

RenovoRx, Inc. completed its initial public offering on NASDAQ on August 26, 2021, pricing at $9.00 a share.

Ticker	RNXT
Exchange	NASDAQ
Status	Completed
Listing date	August 26, 2021
Offering price	$9.00
Shares offered	1,850,000
Total raised	$17M

The offering

RenovoRx, Inc. sold 1,850,000 shares at $9.00 each on NASDAQ. Multiplied out, that is $16.7 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $17 million total recorded for the deal.

Company coverage

RenovoRx, Inc. — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for RenovoRx, Inc.. This page is general information, not investment advice.